Trending Stock News

As Vanda Pharmaceuticals (VNDA) Valuation Declined, Holder Palo Alto Investors Decreased Stake; As T Mobile Us (TMUS) Market Valuation Rose, Shareholder Sadoff Investment Management Cut by $443,470 Its Holding

Sadoff Investment Management Llc decreased its stake in T Mobile Us Inc (TMUS) by 0.92% based on its latest 2017Q3 regulatory filing with the SEC. Sadoff Investment Management Llc sold 7,270 shares as the company’s stock rose 3.83% with the market. The institutional investor held 784,668 shares of the public utilities company at the end of 2017Q3, valued at $48.38M, down from 791,938 at the end of the previous reported quarter. Sadoff Investment Management Llc who had been investing in T Mobile Us Inc for a number of months, seems to be less bullish one the $51.64B market cap company. The stock increased 3.10% or $1.82 during the last trading session, reaching $60.44. About 6.21M shares traded or 46.45% up from the average. T-Mobile US, Inc. (NYSE:TMUS) has risen 62.63% since February 16, 2017 and is uptrending. It has outperformed by 45.93% the S&P500.

William Leland Edwards decreased its stake in Vanda Pharmaceuticals Inc (VNDA) by 1.13% based on its latest 2017Q3 regulatory filing with the SEC. Palo Alto Investors Llc sold 47,600 shares as the company’s stock declined 5.00% while stock markets rallied. The hedge fund run by William Leland Edwards held 4.16M shares of the major pharmaceuticals company at the end of 2017Q3, valued at $74.39M, down from 4.20M at the end of the previous reported quarter. Palo Alto Investors Llc who had been investing in Vanda Pharmaceuticals Inc for a number of months, seems to be less bullish one the $759.28 million market cap company. The stock increased 6.62% or $1.05 during the last trading session, reaching $16.9. About 538,281 shares traded or 5.66% up from the average. Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) has risen 51.60% since February 16, 2017 and is uptrending. It has outperformed by 34.90% the S&P500.

Among 8 analysts covering Vanda Pharmaceuticals (NASDAQ:VNDA), 8 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Vanda Pharmaceuticals had 22 analyst reports since September 2, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Thursday, August 3 by Oppenheimer. The stock of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) earned “Buy” rating by H.C. Wainwright on Thursday, August 3. The firm has “Outperform” rating given on Monday, October 30 by Oppenheimer. The stock of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) has “Buy” rating given on Monday, September 4 by Jefferies. JMP Securities maintained the shares of VNDA in report on Friday, August 26 with “Market Outperform” rating. The company was initiated on Wednesday, November 9 by Aegis Capital. The firm earned “Buy” rating on Tuesday, June 27 by Piper Jaffray. The stock of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) has “Buy” rating given on Wednesday, September 2 by Piper Jaffray. The firm has “Buy” rating given on Wednesday, October 21 by Brean Capital. Jefferies maintained the stock with “Buy” rating in Monday, June 26 report.

Palo Alto Investors Llc, which manages about $1.30 billion and $2.37B US Long portfolio, upped its stake in Epizyme Inc (NASDAQ:EPZM) by 700,000 shares to 6.40M shares, valued at $121.89M in 2017Q3, according to the filing. It also increased its holding in Karyopharm Therapeutics Inc (NASDAQ:KPTI) by 31,010 shares in the quarter, for a total of 3.50M shares, and has risen its stake in Amag Pharmaceuticals Inc (NASDAQ:AMAG).

Since January 2, 2018, it had 0 buys, and 4 selling transactions for $3.36 million activity. 10,367 shares were sold by Gulino Richard L., worth $157,565. The insider Polymeropoulos Mihael Hristos sold $2.93M. On Tuesday, January 2 the insider Birznieks Gunther sold $130,777.

Investors sentiment increased to 1.43 in Q3 2017. Its up 0.26, from 1.17 in 2017Q2. It is positive, as 12 investors sold VNDA shares while 34 reduced holdings. 21 funds opened positions while 45 raised stakes. 38.89 million shares or 4.39% more from 37.25 million shares in 2017Q2 were reported. 3,866 are held by Ameritas Investment Prtn Incorporated. Cadence Capital Mngmt Limited Liability has 62,606 shares. Hbk Investments Limited Partnership stated it has 65,600 shares or 0.01% of all its holdings. Quantbot Limited Partnership holds 0.01% or 3,404 shares. Principal Gru reported 213,898 shares. Parallax Volatility Advisers Lp reported 62,031 shares or 0% of all its holdings. Tudor Corp Et Al has invested 0.01% in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). Meeder Asset Mgmt Incorporated has invested 0.01% in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). Millennium Management Ltd accumulated 1.44 million shares or 0.04% of the stock. Moreover, Orbimed Advsr Ltd Liability Corporation has 0.17% invested in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) for 967,859 shares. Cheyne Cap Management (Uk) Llp accumulated 24,000 shares. Winslow Evans And Crocker accumulated 0% or 70 shares. Qs Invsts Ltd Co invested 0.05% of its portfolio in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). Secor Capital Limited Partnership, a New York-based fund reported 94,272 shares. Point72 Asia (Hong Kong) invested in 0% or 59 shares.

Analysts await Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) to report earnings on February, 21. They expect $-0.12 earnings per share, down 400.00% or $0.16 from last year’s $0.04 per share. After $-0.10 actual earnings per share reported by Vanda Pharmaceuticals Inc. for the previous quarter, Wall Street now forecasts 20.00% negative EPS growth.

Among 32 analysts covering T-Mobile US (NYSE:TMUS), 26 have Buy rating, 1 Sell and 5 Hold. Therefore 81% are positive. T-Mobile US had 76 analyst reports since August 3, 2015 according to SRatingsIntel. Bank of America maintained it with “Underperform” rating and $45 target in Friday, February 9 report. The stock of T-Mobile US, Inc. (NASDAQ:TMUS) earned “Buy” rating by Goldman Sachs on Tuesday, May 23. The rating was initiated by Nomura with “Buy” on Friday, October 16. The company was upgraded on Monday, August 29 by Wells Fargo. The stock has “Buy” rating by SunTrust on Friday, November 17. On Thursday, July 21 the stock rating was maintained by Jefferies with “Buy”. On Wednesday, October 11 the stock rating was maintained by KeyBanc Capital Markets with “Buy”. The firm has “Underperform” rating given on Tuesday, October 24 by Bank of America. On Tuesday, November 21 the stock rating was upgraded by HSBC to “Buy”. The stock of T-Mobile US, Inc. (NASDAQ:TMUS) has “Buy” rating given on Monday, June 13 by Citigroup.

Investors sentiment decreased to 1.06 in 2017 Q3. Its down 0.30, from 1.36 in 2017Q2. It turned negative, as 62 investors sold TMUS shares while 161 reduced holdings. 67 funds opened positions while 169 raised stakes. 279.18 million shares or 0.29% more from 278.36 million shares in 2017Q2 were reported. Gilder Gagnon Howe And Limited Company invested in 5,102 shares. Parametric Associates Limited Liability Com invested 0.04% in T-Mobile US, Inc. (NASDAQ:TMUS). Smithfield Company stated it has 1,804 shares. Moreover, Next Gru has 0.02% invested in T-Mobile US, Inc. (NASDAQ:TMUS) for 1,202 shares. Automobile Association has 378,943 shares. Fincl Architects Incorporated accumulated 70 shares. Hudock Gru Limited Liability Company accumulated 750 shares or 0.02% of the stock. California-based Fuller Thaler Asset Mngmt Inc has invested 0.04% in T-Mobile US, Inc. (NASDAQ:TMUS). Efg Asset Mgmt (Americas) Corporation has invested 0.88% in T-Mobile US, Inc. (NASDAQ:TMUS). Css Ltd Liability Corporation Il owns 0.02% invested in T-Mobile US, Inc. (NASDAQ:TMUS) for 6,182 shares. State Bank Of America De holds 0.01% of its portfolio in T-Mobile US, Inc. (NASDAQ:TMUS) for 909,308 shares. Bkd Wealth Advsr Limited Liability Corporation reported 3,302 shares. Great West Life Assurance Can holds 0.03% of its portfolio in T-Mobile US, Inc. (NASDAQ:TMUS) for 198,719 shares. Daiwa Sb Invests Ltd invested in 0.24% or 14,530 shares. Central Fincl Bank & invested in 0.06% or 3,598 shares.

Sadoff Investment Management Llc, which manages about $850.19 million and $1.12 billion US Long portfolio, upped its stake in Schwab Charles Corp New (NYSE:SCHW) by 9,800 shares to 917,195 shares, valued at $40.12M in 2017Q3, according to the filing. It also increased its holding in Apple Inc (NASDAQ:AAPL) by 12,193 shares in the quarter, for a total of 19,469 shares, and has risen its stake in Alliancebernstein Holding Lp (NYSE:AB).

Leave a Reply

Your email address will not be published. Required fields are marked *